LifeTech Scientific Corp (1302.HK)
Company Info
Highlights
HK$6.91B
31.40
HK$1.24 - HK$2.07
HK$2.44
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
Loading data...
Returns By Period
LifeTech Scientific Corp (1302.HK) returned 12.95% year-to-date (YTD) and -15.59% over the past 12 months. Over the past 10 years, 1302.HK returned 0.75% annually, underperforming the S&P 500 benchmark at 10.46%.
1302.HK
12.95%
13.77%
-5.42%
-15.59%
-2.54%
0.75%
^GSPC (Benchmark)
-3.77%
7.44%
-5.60%
8.37%
14.12%
10.46%
Monthly Returns
The table below presents the monthly returns of 1302.HK, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | -6.47% | 25.38% | 0.61% | -12.20% | 9.03% | 12.95% | |||||||
| 2024 | -27.23% | 16.37% | -11.56% | -2.27% | -1.74% | -17.75% | 5.04% | -3.42% | 23.40% | -4.02% | -11.38% | -6.08% | -40.85% |
| 2023 | 20.93% | -6.41% | -4.45% | -1.79% | -14.96% | 14.59% | 1.87% | -10.29% | -1.64% | 0.00% | -0.00% | -2.08% | -8.91% |
| 2022 | -12.02% | -4.04% | -15.21% | -15.27% | 9.01% | 19.42% | -7.61% | -3.75% | 1.56% | -5.75% | 2.03% | 2.79% | -29.51% |
| 2021 | 10.56% | -20.53% | -8.70% | 17.37% | 22.43% | 0.39% | -15.73% | -3.23% | -2.86% | -11.27% | 16.85% | -13.48% | -17.75% |
| 2020 | -6.04% | 9.29% | 15.69% | -3.39% | -0.00% | 42.69% | -8.61% | 4.48% | -16.31% | 1.03% | 71.07% | 32.05% | 198.66% |
| 2019 | 12.67% | -1.78% | 1.20% | -1.79% | -2.42% | -11.80% | 4.23% | -2.70% | -4.17% | -3.62% | 0.75% | 11.19% | -0.67% |
| 2018 | 10.70% | -9.66% | 21.93% | 5.70% | 19.09% | -13.59% | -10.89% | -13.12% | 0.52% | -11.92% | -5.29% | -6.83% | -19.79% |
| 2017 | -4.30% | 11.24% | -1.01% | 2.04% | -6.00% | -1.60% | -7.03% | 0.58% | 6.36% | 4.89% | -7.25% | 4.47% | 0.54% |
| 2016 | -11.49% | -6.11% | 4.88% | 2.33% | 6.06% | 2.14% | 0.70% | 7.64% | 25.81% | -5.64% | 8.15% | -6.53% | 25.68% |
| 2015 | 20.00% | -18.67% | 14.75% | 2.86% | 70.14% | -9.39% | -39.64% | -19.40% | 3.70% | 33.04% | -6.71% | 6.47% | 18.40% |
| 2014 | 8.00% | 52.01% | 2.13% | 10.74% | 3.23% | 20.52% | -3.03% | -11.76% | 4.55% | -8.55% | -11.46% | -0.40% | 66.67% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of 1302.HK is 45, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for LifeTech Scientific Corp (1302.HK) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Loading data...
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading data...
Worst Drawdowns
The table below displays the maximum drawdowns of the LifeTech Scientific Corp. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the LifeTech Scientific Corp was 77.62%, occurring on Jan 22, 2025. The portfolio has not yet recovered.
The current LifeTech Scientific Corp drawdown is 72.11%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -77.62% | Jan 26, 2021 | 982 | Jan 22, 2025 | — | — | — |
| -64.58% | Jun 23, 2015 | 44 | Aug 24, 2015 | 665 | May 9, 2018 | 709 |
| -58.36% | May 21, 2018 | 368 | Nov 14, 2019 | 252 | Nov 23, 2020 | 620 |
| -30.29% | Jul 8, 2014 | 151 | Feb 27, 2015 | 53 | May 19, 2015 | 204 |
| -21.85% | Jul 5, 2012 | 10 | Jul 19, 2012 | 47 | Oct 10, 2012 | 57 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading data...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of LifeTech Scientific Corp over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Earnings Per Share
The chart presents the Earnings Per Share (EPS) performance of LifeTech Scientific Corp, comparing actual results with analytics estimates.
Valuation
The Valuation section provides an overview of how LifeTech Scientific Corp is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for 1302.HK, comparing it with other companies in the Medical Devices industry. Currently, 1302.HK has a P/E ratio of 31.4. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for 1302.HK compared to other companies in the Medical Devices industry. 1302.HK currently has a PEG ratio of 0.0. This PEG ratio is low compared to industry peers, which could indicate the stock is undervalued relative to its expected growth.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for 1302.HK relative to other companies in the Medical Devices industry. Currently, 1302.HK has a P/S ratio of 5.3. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for 1302.HK in comparison with other companies in the Medical Devices industry. Currently, 1302.HK has a P/B value of 1.8. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |